J. Steve Bynon, M.D.
email
Director, Division of Immunology and Organ Transplantation
| Contact Information | |
|---|---|
| Academic Office | 713.500.7400 |
| Fax number | 713.500.0785 |
| Executive Assistant | Sherry Gibson |
Dr. Bynon comes to UTHealth from the University of Alabama at Birmingham, where he was the director of the liver transplant and pediatric transplant programs for 18 years. He has performed over 900 liver transplants in his career, and also has extensive experience in pediatric liver and kidney transplantation. Dr. Bynon is nationally recognized for his clinical excellence and his ability to implement systems-based approaches to achieving outstanding patient outcomes.
Clinical Interests
- Adult Liver Transplantation
- Pediatric Liver Transplantation
- Adult Kidney Transplantation
- Pediatric Kidney Transplantation
- Pancreas Transplantation
- Hepatobiliary Surgery for Benign and Malignant Disease
- Surgical Management of Portal Hypertension
- Pancreatic Surgery for Benign and Malignant Disease
Education & Training
- Bachelor of Arts (Biology with honors)
University of Tennessee, Knoxville, Tennessee - Doctor of Medicine
University of Tennessee Center for the Health Sciences, Memphis, Tennessee - Residency and Chief Residency, General Surgery
University of Alabama at Birmingham School of Medicine, Birmingham, Alabama - Fellowship, Transplantation Surgery
University of Nebraska College of Medicine, Omaha, Nebraska
Board Certifications
- American Board of Surgery
Society Memberships
- American Association for the Study of Liver Disease
- American College of Surgeons, Fellow
- American Society of Transplant Surgeons
- American Society of Transplantation
- International Liver Transplantation Society
- Texas Transplantation Society
Awards and Honors
- A.G. Diethelm Chair in Transplantation, 2005–2011
- Dean’s Teaching Excellence Award, UTHealth, 2012
Research Interests
- Pre- and post-transplant clinical outcomes in patients with liver disease
Selected Bibliography
- Sellers MT, Haustein SV, McGuire BM, Jones C, Bynon JS, Diethelm AG, Eckoff DE. Use of preserved vascular homograft in liver transplantation: hepatic artery aneurysms and other complications. American Journal of Transplantation, May 2002;2(5):471-475.
- Abouljoud MS, Kumar MS, Brayman KL,Emre S, Bynon JS. Neoral rescue therapy in transplant patients with intolerance to tacrolimus. Clin Transplant, 2002 Jun; 16(3):168-72.
- Haustein SV, McGuire BM, Eckhoff DE, Hudson Sl, Bynon JS, Sellers MT. Impact of noncompliance and donor/recipient race matching on chronic liver rejection. Transplantation Proceedings, 34(5) 1497-1498, Aug 2002.
- Zoghni,Gilbert J, Patel, Amar D., Ershadi, Reza E., Heo, Jaekyeong, Bynon, John S., Iskandrian, Ami E.: Usefulness of preoperative stress perfusion imaging in predicting prognosis after liver transplantation. The Am J Cardiol, Nov 2003;92(9):1066-1071.
- Arch-Ferrer JI, Smith JK, Bynon S, Eckhoff DE, Sellers MT, bland KI, Heslin MJ. Radio-frequency ablation in cirrhotic patients with hepatocellular carcinoma. Am Surg. 2003 Dec;69(12): 1067-71
- Sellers MT, McGuire BM, Haustein SV, Bynon JS, Hunt SL, Eckhoff DE. Two-dose daclizumab induction therapy in 209 liver transplants ñ A single center analysis. Transplantation, 78(8)1212-7, October 27, 2004.
- McGuire BM, Julian BA, Bynon JS, Cook WJ, King SJ, Curtis JJ, Accortt NA, Eckhoff DE. Brief communication: Glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation. Annals of Internal Medicine, May 16, 2006;144(10):735-741.
- Morgan DE, Lockhart ME, Canon CL, Holcombe MP, Bynon JS. Polycystic liver disease: multimodality imaging for complications and transplant evaluation. Radiographics. 2006 Nov-Dec;26(6):1655-68
- Lang JD, Teng X, Chumley P, Crawford JH, Isbell S, Chacko BK, Liu Y, Jhala N, Crowe DR, Smith AB, Cross RC, Frenette L, Kelley EE, Wilhite DW, Hall CR, Page GP, Gallon M, Bynon JS, Eckhoff DE, Patel RP. Inhaled nitric oxide accelerates restoration of liver function in adults following orthotopic liver transplantation. Journal of Clinical Invest. 2007 Sep;117(9):2583-91
- Howard JH, Tzeng CW, Smith JK, Eckhoff DE, Bynon, JS Want T, Arnoletti JP, Heslin MJ. Radiofrequency ablation for unresectable tumors of the liver. Am Surg, 2008 Jul;74(7):594-600; discussion 600-1.
- Boeka AG, Solomon AC, Lokken K, McGuire BM, Bynon JS. A biopsychosocial approach to liver transplant evaluation in two patients with Wilson’s disease. Psychol Health Med 2011; 16(3):268-78.

